Mannkind (MNKD) Asset Utilization Ratio (2011 - 2026)
Mannkind (MNKD) reported Asset Utilization Ratio of 0.47 for Q1 2026, down 36.57% year-over-year from 0.74 in Q1 2025, and down 13.42% on a QoQ basis from 0.54 in Q4 2025.
Mannkind (MNKD) has 14 years of Asset Utilization Ratio data on file, last reported at 0.47 in Q1 2026.
- Quarterly Asset Utilization Ratio fell 36.57% year-over-year to 0.47 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.47 (down 36.57% YoY) and the FY2025 annual result came in at 0.59, down 10.44% from the prior year.
- Asset Utilization Ratio fell to 0.47 in Q1 2026 per MNKD's latest filing, from 0.54 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.74 in Q1 2025 and bottomed at 0.16 in Q2 2022.
- The 5-year median for Asset Utilization Ratio is 0.52 (2023), against an average of 0.48.
- The widest annual swing landed in 2022, when Asset Utilization Ratio tumbled 40.0%; it then surged 226.71% in 2023.
- Tracing MNKD's Asset Utilization Ratio over 5 years: stood at 0.28 in 2022, then jumped by 81.51% to 0.5 in 2023, then soared by 33.04% to 0.67 in 2024, then dropped by 18.5% to 0.54 in 2025, then declined by 13.42% to 0.47 in 2026.
- Per Business Quant, the three latest MNKD Asset Utilization Ratio figures stand at 0.47 (Q1 2026), 0.54 (Q4 2025), and 0.69 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.60 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.47 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.29 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.37 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.85 |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 0.47 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.47 |
| Dec 31, 2025 | 0.54 |
| Sep 30, 2025 | 0.69 |
| Jun 30, 2025 | 0.73 |
| Mar 31, 2025 | 0.74 |
| Dec 31, 2024 | 0.67 |
| Sep 30, 2024 | 0.59 |
| Jun 30, 2024 | 0.54 |
| Mar 31, 2024 | 0.47 |
| Dec 31, 2023 | 0.50 |
| Sep 30, 2023 | 0.56 |
| Jun 30, 2023 | 0.52 |
| Mar 31, 2023 | 0.37 |
| Dec 31, 2022 | 0.28 |
| Sep 30, 2022 | 0.20 |
| Jun 30, 2022 | 0.16 |
| Mar 31, 2022 | 0.22 |
| Dec 31, 2021 | 0.27 |
| Sep 30, 2021 | 0.33 |
| Jun 30, 2021 | 0.26 |
| Mar 31, 2021 | 0.24 |
| Dec 31, 2020 | 0.49 |
| Sep 30, 2020 | 0.48 |
| Jun 30, 2020 | 0.36 |
| Mar 31, 2020 | 0.38 |
| Dec 31, 2019 | 0.36 |
| Sep 30, 2019 | 0.39 |
| Jun 30, 2019 | 0.42 |
| Mar 31, 2019 | 0.40 |
| Dec 31, 2018 | 0.36 |
| Sep 30, 2018 | 0.30 |
| Jun 30, 2018 | 0.22 |
| Mar 31, 2018 | 0.17 |
| Dec 31, 2017 | 0.17 |
| Sep 30, 2017 | 0.29 |
| Jun 30, 2017 | 2.19 |
| Mar 31, 2017 | 1.85 |
| Dec 31, 2016 | 1.72 |
| Sep 30, 2016 | 1.38 |
| Jun 30, 2014 | 0.00 |
| Mar 31, 2014 | 0.00 |
| Dec 31, 2012 | 0.00 |
| Sep 30, 2012 | 0.00 |
| Dec 31, 2011 | 0.00 |
| Sep 30, 2011 | 0.00 |